Welcome to Pleistocene Park

Welcome to Pleistocene Park

In Arctic Siberia, Russian scientists are trying to stave off catastrophic climate change – by resurrecting an Ice Age biome complete with lab-grown woolly mammoths.

The Atlantic, 2017

Editorial Rating



  • Innovative
  • Scientific
  • Eye Opening


For this scientific essay, Ross Anderson, senior editor at The Atlantic, treks through Siberia with Nikita Zimov, the director of Pleistocene Park. The goal of Zimov's project is to stall climate change by restoring the Mammoth Steppe grasslands ecosystem. One item is still on the to-do list: Resurrect the woolly mammoth. Anderson writes a compelling and objective evaluation of this fantastically ambitious project and the determined actors behind it. getAbstract predicts you will be astonished, concerned and awed – all at the same time.


Deep in Russia’s tundra, 2,500 miles from Novosibirsk, scientist Nikita Zimov takes the forests and scrub to task. The tundra wasn’t always home to forests. During the Pleistocene epoch, the Ice Age, woolly mammoths and other large mammals kept larger vegetation in check, causing the ecosystem to give way to an expanse of grasslands across Beringia called the Mammoth Steppe biome. In 1996, Zimov founded Pleistocene Park with the goal of slowing down the thaw of the Beringia permafrost, which is exceptionally rich in carbon compared with other permafrost regions, to prevent a mass release of carbon dioxide...

About the Author

Ross Andersen is a senior editor at The Atlantic, where supervises the Science, Technology and Health sections.

Comment on this summary

More on this topic

By the same author

The Panopticon Is Already Here
Resurrecting the Woolly Mammoth and Other Climate Moonshots
China’s Belt and Road Could Have Been Great but Now Threatens to Be Disastrous
Five Ways to Win in China’s Changing Mobility Market
It’s Time to Tackle Your Team’s Undiscussables
Why Dead Trees Are ‘the Hottest Commodity on the Planet’
The Staggering Value of Forests – and How to Save Them
Competing in China’s Booming Biopharma Market

Related Channels